The Wall of Remembrance
Father? Husband?
Son? Best mate?
You can remember a friend or relative on this site by adding your message to our unique Wall of Remembrance
Click here to contribute.
Prostate cancer worries?
Concerned about prostate cancer?
An overview of the disease, symptoms, tests and related useful information.
Helping the Prostate Cancer Research Foundation
Make a donation to the William Franklyn Memorial Fund.
Information on how to help the Prostate Cancer Research Foundation, including donating online, organising your own events and leaving a legacy.
Funded Research 2005
TMF/ARA160 - A Novel Mediator of Androgen Receptor Degradation in Hypoxic prostate carcinoma cells
Professor Uri Nir, Faculty of Life Sciences, Bar-Ilan University , Israel
Hypoxia is a prevalent stress in solid tumours, occurring when malignant cells outgrow the carrying capacity of the local vasculature.
We have identified a Golgi resident ‘BC box' containing protein-TMF/ARA160, whose level is down-regulated in prostate tumors in vivo . TMF/ARA160 is dispersed in the cytoplasm of hypoxic prostate carcinoma cells, thereafter recruiting the androgen receptor (AR) to ubiquitination and proteasomal degredation. In the current application we propose to unravel the cellular and molecular factors that regulate the activity of TMF/ARA160. This study will open new ways for prostate cancer intervention, by manipulating the level of the AR.
Project commenced
June 2005
Length of project
2 years
Amount Supported
£40,000
